Brokerages Set Cerner (CERN) PT at $66.16

Shares of Cerner (NASDAQ:CERN) have been assigned a consensus rating of “Hold” from the twenty-three brokerages that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating, twelve have assigned a hold rating and ten have issued a buy rating on the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $66.16.

Several equities analysts have issued reports on CERN shares. BidaskClub lowered Cerner from a “buy” rating to a “hold” rating in a report on Friday, December 22nd. Zacks Investment Research raised Cerner from a “sell” rating to a “hold” rating in a report on Tuesday, December 26th. Robert W. Baird reissued a “buy” rating on shares of Cerner in a report on Wednesday, January 3rd. Citigroup began coverage on Cerner in a report on Thursday, January 4th. They set a “neutral” rating on the stock. Finally, Cantor Fitzgerald raised their price target on Cerner to $83.00 and gave the stock an “overweight” rating in a report on Friday, January 5th.

How to Become a New Pot Stock Millionaire

In related news, Director William D. Zollars sold 4,100 shares of the firm’s stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $62.16, for a total value of $254,856.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Vice Chairman Clifford W. Illig sold 307,700 shares of the firm’s stock in a transaction dated Thursday, March 8th. The shares were sold at an average price of $64.52, for a total transaction of $19,852,804.00. Following the completion of the sale, the insider now owns 1,229,719 shares of the company’s stock, valued at approximately $79,341,469.88. The disclosure for this sale can be found here. In the last 90 days, insiders sold 541,800 shares of company stock valued at $34,353,860. 13.11% of the stock is owned by insiders.

Large investors have recently made changes to their positions in the stock. Cedar Hill Associates LLC acquired a new stake in shares of Cerner during the 4th quarter valued at approximately $200,000. Xact Kapitalforvaltning AB lifted its position in shares of Cerner by 3.7% during the 4th quarter. Xact Kapitalforvaltning AB now owns 47,338 shares of the company’s stock valued at $3,190,000 after acquiring an additional 1,702 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lifted its position in shares of Cerner by 2.0% during the 4th quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 385,067 shares of the company’s stock valued at $25,950,000 after acquiring an additional 7,558 shares during the period. We Are One Seven LLC acquired a new stake in shares of Cerner during the 4th quarter valued at approximately $576,000. Finally, Compagnie Lombard Odier SCmA lifted its position in shares of Cerner by 889.5% during the 4th quarter. Compagnie Lombard Odier SCmA now owns 10,885 shares of the company’s stock valued at $733,000 after acquiring an additional 9,785 shares during the period. Hedge funds and other institutional investors own 78.52% of the company’s stock.

Shares of CERN stock traded down $0.19 during mid-day trading on Friday, hitting $56.98. 745,452 shares of the stock were exchanged, compared to its average volume of 2,759,007. The firm has a market cap of $18,869.13, a price-to-earnings ratio of 25.81, a PEG ratio of 1.65 and a beta of 0.96. Cerner has a 12-month low of $55.29 and a 12-month high of $73.86. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.99 and a current ratio of 3.01.

Cerner (NASDAQ:CERN) last issued its quarterly earnings data on Tuesday, February 6th. The company reported $0.58 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.61 by ($0.03). The firm had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.33 billion. Cerner had a return on equity of 16.82% and a net margin of 16.86%. The business’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period in the previous year, the business posted $0.61 EPS. research analysts predict that Cerner will post 2.42 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Brokerages Set Cerner (CERN) PT at $66.16” was originally published by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of US & international copyright laws. The correct version of this piece of content can be viewed at https://transcriptdaily.com/2018/04/13/brokerages-set-cerner-cern-pt-at-66-16.html.

About Cerner

Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Analyst Recommendations for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply